NUVL - Nuvalent prices $300 million stock offering
2023-10-17 04:34:43 ET
More on Nuvalent
- Nuvalent Stock Gains On Lung Cancer Data, But I'd Only Buy On Dip
- Nuvalent announces $300M offering of Class A common stock
- Nuvalent's drug shows promise in lung cancer patients in preliminary phase 1 data
- Seeking Alpha’s Quant Rating on Nuvalent
- Historical earnings data for Nuvalent
For further details see:
Nuvalent prices $300 million stock offering